Article January 10, 2025 Oral Solid Dose Predictions for 2025. Not surprisingly, industry leaders predict a continued focus on improved adherence via user-friendly dosage forms and designs in both the pharma and nutraceutical spaces. More
Article January 9, 2025 Strategic CDMO Growth in a Dynamic Market. In the highly dynamic world of pharmaceuticals, the CDMO sector is evolving rapidly, driven by increasing demand for specialized development, manufacturing, and packaging services. More
Article January 3, 2025 Accelerating Innovation: Harnessing Parallel Development for Autoinjectors. The transition to such devices requires strategic planning and parallel development can help balance clinical and commercial goals. More
Article December 16, 2024 New Product Introduction and Technical Transfer in a High-Potency Facility. The pharmaceutical industry is increasingly focused on drug products containing highly potent active pharmaceutical ingredients (HPAPIs). More
Article November 26, 2024 Pediatric Drug Development: The Liquid Challenge. In 2023, the FDA released Guidance for Industry, Pediatric Drug Development Under the Pediatric Research Equity Act, and the best Pharmaceuticals for Children Act. More
Article November 4, 2024 CPHI Supplement with PCI Pharma Services: Your trusted partner for scalable CDMO solutions. More
Article October 24, 2024 Clinical Trial Kit Design & Forecasting for the Pharmaceutical and Biopharmaceutical Industry More
Article October 9, 2024 The Multifaceted Future of Pharma. Over the coming decade, one prominent category likely to drive substantial changes in drug development and manufacturing is AI. More
Article October 8, 2024 Advanced Drug Delivery Solutions Showcase. PCI offers expertise and solutions in sterile fill-finish and specialist final assembly and packaging of advanced drug delivery and drug-device combination products. More
